Histopathological findings obtained by uterine curettage due to abortion at the Santa Isabel Maternity (Aracaju-Sergipe-Brazil) in the 2015-2017 period
DOI:
https://doi.org/10.33448/rsd-v10i11.19892Keywords:
Fetal loss; Curettage; Histopathology; Gestational trophiblastic disease.Abstract
Abortion is a common event that directly affects the family, social and health spheres. It is defined by the World Health Organization (WHO) as the expulsion or extraction of the fetus before 20 weeks or weighing less than 500g and has well-defined clinical and histopathological characteristics, ranging from benign conditions to life-threatening pathologies. Aiming to outline the profile of histopathological findings by uterine curettage for abortion in a maternity hospital in the city of Aracaju, State of Sergipe, between 2015 and 2017, a total of 2473 findings were analyzed. Of these, the majority corresponded to incomplete abortion (98.83%) and to products of conception (61.91%). Seven cases of hydatidiform mole were found – four incomplete and three complete. In the profile of the population studied, 91.14% of women did not have partners and 88.31% were single. The abortion rate per ten thousand inhabitants was also analyzed, drawing attention to the fact that the greater Aracaju concentrates a number about four times greater than other municipalities in the state of Sergipe. There is a lot of debate about the high costs of performing routine uterine curettage with histopathological analysis, since the risk of developing gestational trophoblastic disease is low, corresponding to 0.003% in the present study. Although this is true, when comparing the clinical aspect of the abortion with the histopathological findings, a p of 0.23 was found, and it was not possible to reliably establish a clinical profile for potentially malignant conditions.
References
Aldrich, T., & Winikoff, B. (2007). Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion A retrospective analysis of 8678 abortions. International Journal of Obstetrics & Gynaecology, 114(5): 555-562.
Alsibiani, S. A. (2014). Value of histopathologic examination of uterine products after first-trimester miscarriage. BioMed research international, 2(4): 255-256.
Berkowitz, R. S., & Goldstein, D. P. (2009). Molar pregnancy. New England Journal of Medicine, 360(16): 1639-1645.
Berkowitz, R.S., Goldstein, D.P., & Bernstein, M. R. (1985). Natural history of partial molar pregnancy. Obstetrics and gynecology, 66(5): 677-681.
Biscaro, A., Koettker, S. S., Locks, G. F., Mileo, L. R., Silva Júnior, J. P., & Pretto, P. (2012). Frequência de mola hidatiforme em tecidos obtidos por curetagem uterina. Rev Bras Ginecol Obstet, 34(6): 254-258.
Blencowe, H., Cousens, S., Oestergaard, M. Z., Chou, D., Moller, A. B., Narwal, R., et al. (2012). National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. The Lancet, 379 (9832): 2162-2172.
Blohm, F., Fridén, B., Platz-Christensen, J. J., Milsom I., & Nielsen S. (2003). Expectant management of first-trimester miscarriage in clinical practice. Acta obstetricia et gynecologica Scandinavica, 82(7): 654-658.
Condous, G., Okaro, E., & Bourne, T. (2003). The conservative management of early pregnancy complications: a review of the literature. Ultrasound in Obstetrics and Gynecology, 22(4): 420-430.
Creinin, M. D., Moyer, R., & Guido, R. (1997) Misoprostol for medical evacuation of early pregnancy failure. Obstetrics & Gynecology, 89(5): 768-772.
Doubilet, P. M., Benson, C. B., Bourne, T., & Blaivas, M. (2013). Diagnostic criteria for nonviable pregnancy early in the first trimester. New England Journal of medicine, 369(15): 1443-51.
Elias, K. M., Shoni, M., Bernstein, M., Goldstein, D. P., & Berkowitz, R. S. (2012). Complete hydatidiform mole in women aged 40 to 49 years. The Journal of reproductive medicine, 57(5-6): 254-258.
Ellish, N. J. (1996). A prospective study of early pregnancy loss. Human Reproduction, 11(2): 406-412.
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa. Artes Médicas.
Eyk, V. N., Halifax, N. S., Schalkwyk, J., & Vancouver, B. C. (2012). Antibiotic prophylaxis in gynaecologic procedures. Journal of Obstetrics and Gynaecology Canada, 34(4): 382-391.
Farrell, T., Owen, P. (1996). The significance of extrachorionic membrane separation in threatened miscarriage. BJOG: An International Journal of Obstetrics & Gynaecology, 103 (9): 926-928.
Fram, K. M. (2002). Histological analysis of the products of conception following first trimester abortion at Jordan University Hospital. European Journal of Obstetrics & Gynecology and Reproductive Biology, 105(2): 147-149.
Gamble, S. B. (2005). Vigilância do aborto - Estados Unidos, MMWR Surveill Summ, 57(13): 1-32.
Genest, D. R., Laborde, O., Berkowitz, R. S., Goldstein, D. P., Bernstein, M. R., & Lage, J. A. (1991). Clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance. Obstetrics and gynecology, 78(3): 402-409.
Goyal, V. (2009). Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review. Obstetrics & Gynecology, 113(5): 1117-1123.
Heath, V., Chadwick, V., Cooke, I., Manek, S., & Mackenzie, I. Z. (2000). Should tissue from pregnancy termination and uterine evacuation routinely be examined histologically. International Journal of Obstetrics & Gynaecology, 107(6): 727-730.
Holanda, A. A. R., Santos, H. P. F. D., Barbosa, M. F., Barreto, C. F. B., Felinto A. S., & Araújo, I. S. (2003). Tratamento do abortamento do primeiro trimestre da gestação: curetagem versus aspiração manual a vácuo. RBGO, 25(4): 271-6.
Hou, S. P., Fang, A. H., Chen, Q. F., Huang, Y. M., Chen, O. J., & Cheng, L. N. (2011). Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials. Contraception, 84(3): 214-223.
Jones, H. E., White, K. O., Norman, W. V., Guilbert, E., Lichtenberg, E. S., & Paul, M. (2017). First trimester medication abortion practice in the United States and Canada. PloS one, 12(10): 12-18.
Kapp, N., Whyte, P., Tang, J., Jackson, E., & Brahmi, D. (2013). A review of evidence for safe abortion care. Contraception, 88(3): 350-363.
Kocke, J. C. (2011). Fundamentos de metodologia científica. Vozes. http://www.brunovivas.com/wp-content/uploads/sites/10/2018/07/K%C3%B6che-Jos%C3%A9-Carlos0D0AFundamentos-de-metodologia-cient%C3%ADfica-_-teoria-da0D0Aci%C3%AAncia-e-inicia%C3%A7%C3%A3o-%C3%A0-pesquisa.pdfhttp s://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1
Kulier, R. et al. (2011). Medical methods for first trimester abortion. Cochrane database of systematic reviews, 11, 1-5.
Kumar, V., Abbas, A., & Aster, J. C. R. (2015). Patologia-bases patológicas das doenças. Elsevier Brasil.
Ludke, M. & Andre, M. E. D. A. (2013). Pesquisas em educação: uma abordagem qualitativa. E.P.U.
Luise, C. et al. (2002). Expectant management of incomplete, spontaneous first‐trimester miscarriage: outcome according to initial ultrasound criteria and value of follow‐up visits. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 19(6): 580-582.
Lurain, J. R. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. American journal of obstetrics and gynecology, 203(6): 531-539.
Ngan, S., & Seckl, M. J. (2007). Gestational trophoblastic neoplasia management: an update. Current opinion in oncology, 19(5): 486-491.
Ngo, T. D., Park, M. H., & Free, C. (2013). Safety and effectiveness of termination services performed by doctors versus midlevel providers: a systematic review and analysis. International journal of women's health, 5-9.
Nielsen, S., Hahlin, M. (1995). Expectant management of first-trimester spontaneous abortion. The Lancet, 345(8942): 84-85.
Organització Mundial De La Salut et al. (2003). Safe Abortion: technical and policy guidance for health systems. World Health Organization.
Passos, E., P, et al. (2017). Rotinas em ginecologia. Artmed Editora.
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. UFSM.
Peyron, R., Aubény, E., Targosz, V., Silvestre, L., Renault, M., Elkik, F., et al. (1993). Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. New England Journal of Medicine, 328(21): 1509-1513.
Rashid, P. A. (2017). The role of histopathological examination of the products of conception following first-trimester miscarriage in Erbil Maternity Hospital. Zanco Journal of Medical Sciences, 21(3): 1938-1942.
Salter, C., Johnson, H. B., & Hengen, N. (1997). O tratamento das complicações pós-aborto: Uma intervenção para salvar a vida da mulher. Population Reports, (10):1-28.
Sawaya, G. F., Grady, D., Kerlikowske, K., & Grimes D. A. (1996). Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstetrics & Gynecology, 87(5): 884-890.
Schaff, E. A., Fielding, S. L., Eisinger, S. H., Stadalius, L. S., & Fuller L. (2000). Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception, 61(1): 41-46.
Seckl, M. J., Sebire, N. J., & Berkowitz, R. S. (2010). Gestational trophoblastic disease. The Lancet, 376(9742): 717-729.
Sedgh, G., Bearak, J., Singh, S., Bankole, A., Popinchalk, A., Ganatra, B., et al. (2016). Abortion incidence between 1990 and 2014: global, regional, and subregional lev.els and trends. The Lancet, 388(10041): 258-267.
Silvestre, L., Dubois, C., Renault, M., Rezvani, Y., Baulieu, E., & Ulmann, A. (1990). Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue: a large-scale French experience. New England Journal of Medicine, 322(10): 645-648.
Soto-Wright, V., Bernstein, M., Goldstein, D. P., & Berkowitz, R. S. (1995). The changing clinical presentation of complete molar pregnancy. Obstetrics & Gynecology, 86(5): 775-779.
Spitz, I. M., Bardin, C. W., Benton, L., & Robbins, A. (1998). Early pregnancy termination with mifepristone and misoprostol in the United States. New England Journal of Medicine, v. 338, n. 18, p. 1241-1247.
Tasci, Y., Dilbaz, S., Secilmis, O., Ilbaz, B., Ozfuttu, A., & Haberal, A. (2005). Routine histopathologic analysis of product of conception following first‐trimester spontaneous miscarriages. Journal of Obstetrics and Gynaecology Research, 31(6): 579-582.
Torres, J., Díaz, J., & Gutiérrez, M. (1997). Mortalidad materna en el Instituto Materno Perinatal en el quinquenio 1991-1995. Revista Peruana de Ginecología y Obstetricia, 43(2): 152-157.
Vassilakos, P., Riotton, G., & Kajii, T. (1997). Hydatidiform mole: two entities: a morphologic and cytogenetic study with some clinical considerations. American journal of obstetrics and gynecology, 127(2): 167-170.
Warburton, D., Fraser, F. C. (1964). Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. American journal of human genetics, 16(1),1.
Wiebe, E. R. Trouton, K. J., & Lima, R. (2006). Misoprostol alone vs. methotrexate followed by misoprostol for early abortion. International Journal of Gynecology & Obstetrics, 95(3): 286-287.
Winikoff, B., Dzuba, I. G., Chong, E., Goldberg, A., Lichtenberg, E. S., & Ball. (2012). Extending outpatient medical abortion services through 70 days of gestational age. Obstetrics & Gynecology, 120(5): 1070-1076.
Yin, R. K. (2015). O estudo de caso. Bookman.
Zhao, J., Lv, W. G., Feng, F. Z., Wan, X. R., Liu, J. H., Yi, X. F., et al. (2016). Placental site trophoblastic tumor: a review of 108 cases and their implications for prognosis and treatment. Gynecologic oncology, 142(1): 102-108.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Fellipe Almeida de Novais; Marina de Pádua Nogueira Menezes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
